Cutera Announces Preliminary Record Third Quarter 2016 Revenue
Oct 11, 2016 11:30 am UTC| Business
Approximately $30 million of revenue, representing 30% growth year-over-yearRevenue achievement represents record third quarter, and among the highest quarters, in Company historyNine consecutive quarters of double-digit...
Xtant™ Medical Pre-Announces Record Third Quarter 2016 Revenue
Oct 11, 2016 11:30 am UTC| Business
*See footnote about the use of pro forma financial information Record Third Quarter 2016 Revenue in the range of $23.0 million to $23.3 millionThird Quarter 2016 Revenue represents an increase of 10.0% to 11.5%...
FTI Consulting Appoints Sophie Ross as Global Chief Executive Officer of the Technology Segment
Oct 11, 2016 11:30 am UTC| Business
WASHINGTON, Oct. 11, 2016 -- FTI Consulting, Inc. (NYSE:FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, today announced the appointment of Sophie...
Karyopharm to Present at the 15th Annual BIO Investor Forum
Oct 11, 2016 11:30 am UTC| Business
NEWTON, Mass., Oct. 11, 2016 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Justin A. Renz, Executive Vice President, Chief Financial Officer, and Treasurer,...
Oct 11, 2016 11:15 am UTC| Business
DEERFIELD, Ill., Oct. 11, 2016 -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) (“SCA”) today announced that it intends to pursue a refinancing of its existing term loan facility, under which $444.4 million is currently...
Oct 11, 2016 11:11 am UTC| Business
NEW YORK, Oct. 11, 2016 -- HC2 Holdings, Inc. (“HC2”) (NYSE MKT:HCHC), a diversified holding company, announced today that its operating subsidiary DBM Global Inc. (“DBM Global”) (OTC:DBMG), a family of companies...
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Oct 11, 2016 11:05 am UTC| Business
LEXINGTON, Mass., Oct. 11, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers,...